|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/42 | |
| A61K 47/64 | |||
| A61K 39/00 | |||
| C07K 17/14 | |||
| C12N 5/00 | |||
| A61P 35/00 |
| (11) | Number of the document | 2376110 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10729571.9 |
| Date of filing the European patent application | 2010-01-08 | |
| (97) | Date of publication of the European application | 2011-10-19 |
| (45) | Date of publication and mention of the grant of the patent | 2019-03-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/020504 |
| Date | 2010-01-08 |
| (87) | Number | WO 2010/081004 |
| Date | 2010-07-15 |
| (30) | Number | Date | Country code |
| 143713 P | 2009-01-09 | US | |
| 152205 P | 2009-02-12 | US | |
| 175719 P | 2009-05-05 | US | |
| 264222 P | 2009-11-24 | US |
| (72) |
SIEVERS, Eric, US
KENNEDY, Dana, US
IHLE, Nathan, US
SUN, Michael, US
|
| (73) |
Seattle Genetics, Inc.,
21823 30th Drive, S.E., Bothell, WA 98021,
US
|
| (54) | WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES |
| WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES |